MedTrace Logo

Impact of Ultra-Processed Food Intake on Gingival Tissue Health

NCT06411535 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2024-10-30

No results posted yet for this study

Summary

The shift towards consuming more industrialized food products, particularly ultra-processed foods, has been linked to a rise in non-communicable diseases globally. These products are energy-dense, high in unhealthy components, and often lead to overconsumption due to their palatability and convenience. Studies suggest a connection between ultra-processed food consumption and various health issues, including obesity and cardiovascular diseases. The present study is designed as a single-center, double-blind, parallel-arm randomized clinical trial. This study aims to investigate the impact of ultra-processed food consumption on gingival health and to evaluate the potential benefits of dietary counseling and reduced ultra-processed food intake on gingival inflammation over a 4-month period.

Conditions

  • Gingivitis
  • Ultra-processed Food
  • Prevention

Interventions

BEHAVIORAL

Full-mouth ultrasonic debridement plus Nutritional counseling

After diagnosis of gingivitis, patients will receive a nutritional counseling focused on ultra-processed foods entails educating individuals about the nutritional content and potential health implications of highly processed food products. They will undergo a session of full-mouth ultrasonic debridement and reinforcment of dietary counseling. Between consecutive time points, patients will receive motivational emails.

OTHER

Full-mouth ultrasonic debridement

After diagnosis of gingivitis, patients will receive a session of full mouth ultrasonic debridement

Sponsors & Collaborators

  • University of Siena

    lead OTHER

Principal Investigators

  • Nicola Discepoli, DDS MSc PhD · Department of Medical Biotechnologies, University of Siena

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-21
Primary Completion
2024-10-28
Completion
2024-10-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06411535 on ClinicalTrials.gov